Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday preview: US CPI, AstraZeneca in focus

Wed, 09th Feb 2022 18:32

(Sharecast News) - Investors' attention will be firmly on the latest consumer price due out in the US covering the month of January.
The Department of Labor is expected to report that the annual rate of consumer price inflation accelerated from a clip of 7.1% in December to 7.3%.

Core CPI is also expected to have picked up the pace, from 5.5% to 5.9%.

Meanwhile, the market spotlight in Europe will be on speeches from European Central Bank vice-president, Luis de Guindos, and the bank's chief economist, Philip Lane, at 1200 GMT and 1315 GMT, respectively.

Against that backdrop, officials at Sweden's central bank will make a policy announcement at 0830 GMT.

On home shores, overnight the Royal Institute of Chartered Surveyors will release its house price balance for the month of January.

Further afield, in Indonesia, rate-setters are due to meet to decide on monetary policy with the consensus being that the seven-day reverse repurchase rate will be unchanged at 3.50%.

In the corporate space, and for AstraZeneca's fourth quarter numbers, UBS analyst Michael Leuchten says that investors' focus will be on the performance of the underlying business following the acquisition of Alexion mid-year.

Their attention will also be on the key drivers of the drug giant's top-line growth, sales of Tagrisso, Lynparza and Imfinzi, all of which fell short of analysts' estimates in the third quarter.

So too, Leuchten added, investors were keen for additional commentary around the company's latest clinical success, the PROPEL trial for Lynparza.

For the fourth quarter, Leuchten had penciled in a 52.9% jump in sales to approximately $11.33bn for a 61.8% surge in core earnings before interest and tax to $3.07bn.

Thursday 10 February

INTERIMS

Ashmore Group, MJ Gleeson , Redrow

INTERIM DIVIDEND PAYMENT DATE

Ashtead Group

INTERIM EX-DIVIDEND DATE

Henderson Smaller Companies Inv Trust

QUARTERLY EX-DIVIDEND DATE

Custodian Reit , ICG Enterprise Trust, INTERNATIONAL BUSINESS MACHINES CORPORATION COM STK USD0.20 (CDI), The Renewables Infrastructure Group Limited

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Consumer Price Index (US) (13:30)

Continuing Claims (US) (13:30)

Initial Jobless Claims (US) (13:30)

Q4

AstraZeneca, Unilever

GMS

SEC Newgate S.P.A. NPV (CDI)

FINALS

AstraZeneca, PJSC MNC Norilsk Nickel ADR, Relx plc, Unilever

SPECIAL DIVIDEND PAYMENT DATE

Unicorn AIM VCT

AGMS

Benchmark Holdings , easyJet, Tritax Eurobox (GBP)

TRADING ANNOUNCEMENTS

Royal Mail, Watches of Switzerland Group

UK ECONOMIC ANNOUNCEMENTS

Balance of Trade (07:00)

GDP (Preliminary) (07:00)

Gross Domestic Product (07:00)

Index of Services (07:00)

Industrial Production (07:00)

Manufacturing Production (07:00)

RICS Housing Market Survey (00:01)

FINAL DIVIDEND PAYMENT DATE

Hargreave Hale AIM VCT , Sage Group, Smiths News , Unicorn AIM VCT

FINAL EX-DIVIDEND DATE

Aberforth Smaller Companies Trust, Avon Protection, Impax Asset Management Group, Virgin Money UK
More News
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.